📣 VC round data is live. Check it out!

ALT5 Sigma Valuation Multiples

Discover ALT5 Sigma's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Next Technology Holding, Prairie Operating Co., Neptune Digital Assets, Solana and more.

ALT5 Sigma Overview

About ALT5 Sigma

ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.


Founded

1983

HQ

United States

Employees

10

Financials (LTM)

Revenue: $29M
Net Income: ($190M)

EV

$129M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

ALT5 Sigma Financials

ALT5 Sigma reported last 12-month revenue of $29M.

In the same LTM period, ALT5 Sigma generated $18M in gross profit and had net loss of ($190M).

Revenue (LTM)


ALT5 Sigma P&L

In the most recent fiscal year, ALT5 Sigma reported revenue of - and net income of -.

See analyst estimates for ALT5 Sigma
LTM2025202620272028
Revenue$29M$25M
Gross Profit$18M$10M
Gross Margin61%40%
EBIT Margin(4%)(92%)
Net Profit($190M)($345M)
Net Margin(647%)(1387%)

Financial data powered by Morningstar, Inc.

ALT5 Sigma Stock Performance

ALT5 Sigma has current market cap of $120M, and enterprise value of $129M.

Market Cap Evolution


ALT5 Sigma's stock price is $0.85.

ALT5 Sigma share price decreased by 88.2% in the last year.

See more trading valuation data for ALT5 Sigma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$129M$120M0.0%--23.0%-88.2%-

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

ALT5 Sigma Valuation Multiples

ALT5 Sigma trades at 4.4x EV/Revenue multiple.

See NTM and 2027E valuation multiples for ALT5 Sigma

ALT5 Sigma Financial Valuation Multiples

As of June 4, 2026, ALT5 Sigma has market cap of $120M and EV of $129M.

ALT5 Sigma has a P/E ratio of (0.6x).

LTM2025202620272028
EV/Revenue4.4x5.2x
EV/EBIT(98.6x)(5.7x)
EV/Gross Profit7.2x12.9x
P/E(0.6x)(0.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified ALT5 Sigma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

ALT5 Sigma Margins & Growth Rates

See estimated margins and future growth rates for ALT5 Sigma

ALT5 Sigma Margins

20252026202720282029
Gross Margin40%80%
EBIT Margin(92%)79%
Net Margin(1387%)58%

ALT5 Sigma Growth Rates

25/2626/2727/2828/29
Revenue Growth44%
Gross Profit Growth184%
EBIT Growth(223%)
Net Profit Growth(106%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

ALT5 Sigma Competitors

ALT5 Sigma competitors include Next Technology Holding, Prairie Operating Co., Neptune Digital Assets, Solana, Amber International, Bitcoin Group, BTCS, WonderFi, Hyperion DeFi and Capital B.

Most ALT5 Sigma public comparables operate across Crypto & Web3 Platforms and FinTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Next Technology Holding(3.9x)-0.6x-
Prairie Operating Co.2.4x2.0x3.7x3.2x
Neptune Digital Assets68.1x68.1x86.5x-
Solana15.3x9.8x(2.3x)-
Amber International1.4x1.5x18.2x20.0x
Bitcoin Group14.2x-45.6x-
BTCS0.2x0.2x(0.1x)-
WonderFi4.7x-(6.2x)-

This data is available for Pro users. Sign up to see all ALT5 Sigma competitors and their valuation data.

Start Free Trial

ALT5 Sigma VC Funding History

Before going public, ALT5 Sigma raised $6M in total equity funding, across 1 round.


ALT5 Sigma Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jan-21Secondary - publicArmando Soto$6M--

Acquisitions by ALT5 Sigma

ALT5 Sigma has acquired 5 companies to date.

Last acquisition by ALT5 Sigma was on April 29th 2026. ALT5 Sigma acquired Blockstreet for $43M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by ALT5 Sigma

Blockstreet
Mswipe
ALT5 Sigma
Soin Therapeutics
Description
Blockstreet is a blockchain-based finance platform that issues the USD1 stablecoin and delivers decentralized finance solutions.
Mswipe is a Canadian provider of secure mobile point-of-sale solutions certified for payment processing. Based in Toronto, it equips merchants with hardware and software for contactless transactions including EMV and NFC. The platform integrates with major card networks and supports small businesses across Ontario and Quebec. Established in 2015, Mswipe processes millions in transactions yearly with PCI-compliant security features.
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
Soin Therapeutics is a U.S.-based biopharma company advancing treatments for complex regional pain syndrome and orphan neurological disorders. The firm develops low-dose naltrexone formulations and novel peptides targeting neuroinflammation, with Phase II trials underway at 20 U.S. sites. Soin Therapeutics holds FDA orphan drug designations and partners with universities for preclinical models.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Los Angeles, CA
-
Greenwich, CT
Dayton, OH
Deal Date29 Apr 202613 May 202510 May 202416 Sep 2022
Valuation$43M$6Mundisclosed$13M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ALT5 Sigma acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About ALT5 Sigma

When was ALT5 Sigma founded?ALT5 Sigma was founded in 1983.
Where is ALT5 Sigma headquartered?ALT5 Sigma is headquartered in United States.
How many employees does ALT5 Sigma have?As of today, ALT5 Sigma has over 10 employees.
Who is the CEO of ALT5 Sigma?ALT5 Sigma's CEO is Tony Isaac.
Is ALT5 Sigma publicly listed?Yes, ALT5 Sigma is a public company listed on Nasdaq.
What is the stock symbol of ALT5 Sigma?ALT5 Sigma trades under ALTS ticker.
When did ALT5 Sigma go public?ALT5 Sigma went public in 1991.
Who are competitors of ALT5 Sigma?ALT5 Sigma main competitors include Next Technology Holding, Prairie Operating Co., Neptune Digital Assets, Solana, Amber International, Bitcoin Group, BTCS, WonderFi, Hyperion DeFi, Capital B.
What is the current market cap of ALT5 Sigma?ALT5 Sigma's current market cap is $120M.
What is the current revenue of ALT5 Sigma?ALT5 Sigma's last 12 months revenue is $29M.
What is the current revenue growth of ALT5 Sigma?ALT5 Sigma revenue growth (NTM/LTM) is 44%.
What is the current EV/Revenue multiple of ALT5 Sigma?Current revenue multiple of ALT5 Sigma is 4.4x.
Is ALT5 Sigma profitable?No, ALT5 Sigma is not profitable.
What is the current net income of ALT5 Sigma?ALT5 Sigma's last 12 months net income is ($190M).
How many companies ALT5 Sigma has acquired to date?As of June 2026, ALT5 Sigma has acquired 5 companies.
What was the largest acquisition by ALT5 Sigma?$43M acquisition of Blockstreet on 29th April 2026 was the largest M&A ALT5 Sigma has done to date.
What companies ALT5 Sigma acquired?ALT5 Sigma acquired Blockstreet, Soin Therapeutics, Mswipe, ALT5 Sigma, and GeoTraq.
In how many companies ALT5 Sigma has invested to date?ALT5 Sigma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to ALT5 Sigma

Lists including ALT5 Sigma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial